DS-5565
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for DS-5565, covering 2020-07-23 to 2022-10-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain [Phase 3]